Neuland Laboratories Limited EBITDA Margin for the year ending March 31, 2025: 28.45%

Neuland Laboratories Limited EBITDA Margin is 28.45% for the year ending March 31, 2025, a -6.61% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Neuland Laboratories Limited EBITDA Margin for the year ending March 31, 2024 was 30.46%, a 26.68% change year over year.
  • Neuland Laboratories Limited EBITDA Margin for the year ending March 31, 2023 was 24.05%, a 58.15% change year over year.
  • Neuland Laboratories Limited EBITDA Margin for the year ending March 31, 2022 was 15.21%, a -14.30% change year over year.
  • Neuland Laboratories Limited EBITDA Margin for the year ending March 31, 2021 was 17.74%, a 35.08% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin